In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Hims & Hers Health Inc’s stock clocked out at $33.14, up 5.07% from its previous closing price of $31.54. In other words, the price has increased by $5.07 from its previous closing price. On the day, 17.04 million shares were traded. HIMS stock price reached its highest trading level at $33.29 during the session, while it also had its lowest trading level at $31.5101.
Ratios:
To gain a deeper understanding of HIMS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.12. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 11 ’25 when Becklund Irene sold 2,203 shares for $34.77 per share. The transaction valued at 76,598 led to the insider holds 2,203 shares of the business.
Becklund Irene bought 2,203 shares of HIMS for $76,598 on Mar 11 ’25. On Mar 03 ’25, another insider, Becklund Irene, who serves as the PAO of the company, sold 2,913 shares for $45.14 each. As a result, the insider received 131,493 and left with 4,406 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 7362580992 and an Enterprise Value of 7073660928. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.97, and their Forward P/E ratio for the next fiscal year is 38.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.00. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.99 while its Price-to-Book (P/B) ratio in mrq is 15.35. Its current Enterprise Value per Revenue stands at 4.791 whereas that against EBITDA is 85.139.
Stock Price History:
The Beta on a monthly basis for HIMS is 1.64, which has changed by 1.1135204 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -12.18%, while the 200-Day Moving Average is calculated to be 30.11%.
Shares Statistics:
It appears that HIMS traded 20.89M shares on average per day over the past three months and 23747750 shares per day over the past ten days. A total of 212.46M shares are outstanding, with a floating share count of 182.04M. Insiders hold about 18.06% of the company’s shares, while institutions hold 73.63% stake in the company. Shares short for HIMS as of 1740700800 were 51844511 with a Short Ratio of 2.48, compared to 1738281600 on 58208349. Therefore, it implies a Short% of Shares Outstanding of 51844511 and a Short% of Float of 26.520001999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
